ESR1 MUTATIONS IN ADVANCED/METASTATIC
BREAST CANCER
KNOWING THE ESR1 MUTATION STATUS CAN MAKE ALL THE DIFFERENCE
MUTATIONS IN ESR1 MAKE IT A KEY BIOMARKER IN ADVANCED/METASTATIC BREAST CANCER (a/mBC)
This information portal will help you understand the role of ESR1 mutations in a/mBC
Headshots are not actual HCPs or patients. For illustrative purposes only.
*e.g. Oncologists interested in a/mBC, pathologists, molecular biologists, and research scientists.
a/mBC: advanced/metastatic breast cancer; ER+: oestrogen receptor-positive; ESR1: oestrogen receptor 1; FAQs: frequently asked questions; HCP: healthcare professional; HER2-: human epidermal growth factor receptor 2-negative.